Hyperbaric oxygen therapy for radiation‐induced hemorrhagic cystitis

Yoshida, Takahiro; Kawashima, Atsunari; Ujike, Takeshi; Uemura, Mamoru; Nishimura, Kensaku; Miyoshi, S

doi:10.1111/j.1442-2042.2008.02053.x

Cited by 46 publications

(54 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Moreover, some of them may have serious systematic side effects or may exacerbate bladder fibrosis which was initiated by radiation treatment, leading to a small-capacity bladder (1,(2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13)(14). A recent Cochrane Database systematic literature review on non-surgical interventions for late radiation cystitis in patients who have received radical radiotherapy to the pelvis concluded that in the absence of randomized controlled studies it is impossible to set definitive rules for treatment (21).…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Is there a role for hyberbaric oxygen as primary treatment for grade IV radiation-induced haemorrhagic cystitis? a prospective pilot-feasibility study and review of literature

et al. 2014

View full text Add to dashboard Cite

ARTICLE INFO ______________________________________________________________ ______________________Purpose: To examine the safety and efficacy of hyperbaric oxygen as the primary treatment for Grade IV radiation-induced haemorrhagic cystitis. Materials and Methods:Hyperbaric oxygen was prospectively applied as a primary treatment option in 11 patients with Grade IV radiation cystitis. Primary endpoint was the incidence of complete and partial response to treatment. Secondary endpoints included the duration of response, the correlation of treatment success-rate to the interval between the onset of haematuria and initiation of therapy, blood transfusion need and total radiation dose, the number of sessions to success, the avoidance of surgery and the overall survival.Results: All patients completed therapy without complications for a mean follow-up of 17.82 months (range 3 to 34). Mean number of sessions needed was 32.8 (range 27 to 44). Complete and partial response rate was 81.8% and 18.2%, respectively. However, in three patients the first treatment session was not either sufficient or durable giving a 72.7% rate of durable effect. Interestingly, all 9 patients with complete response received therapy within 6 months of the haematuria onset compared to the two patients with partial response who received therapy at 8 and 10 months from the haematuria onset, respectively (p = 0.018). The need for blood transfusion (p = 0.491) and the total radiation dose (p = 0.259) were not correlated to success-rate. One patient needed cystectomy, while all patients were alive at the end of follow-up. Conclusions: Early primary use of hyperbaric oxygen to treat radiation-induced grade IV cystitis is an effective and safe treatment option.

show abstract

Section: Discussionmentioning

confidence: 99%

“…All studies published on HBO therapy for radiation cystitis are not randomized or controlled. The majority constitutes retrospective reviews and case series (2)(3)(4)(5)(6)(7)(8)(9)(10)(11)(12)(13), with only one study being prospective in nature (14). In all these studies HBO was used as a secondary treatment option.…”

Section: Introductionmentioning

confidence: 99%

Is there a role for hyberbaric oxygen as primary treatment for grade IV radiation-induced haemorrhagic cystitis? a prospective pilot-feasibility study and review of literature

et al. 2014

View full text Add to dashboard Cite

show abstract

“…The relatively high levels of oxygen deliverable under HBO exposure make this approach attractive. Several studies in experimental animal tumors have shown that HBO reduces the radioresistance of certain types of tumors [6][7][8][9] and enhances the anticancer activity of doxorubicin and other alkylating agents. 10,11 Clinical trials have been initiated to study the effect of HBO inhalation on the radiotherapy for many types of malignant tumors.…”

Section: Introductionmentioning

confidence: 99%

Oxygenation inhibits ovarian tumor growth by down-regulating STAT3 and cyclin-D1 expressions

Selvendiran¹,

Kuppusamy²,

Ahmed³

et al. 2010

Cancer Biology & Therapy

View full text Add to dashboard Cite

“…A number of investigators have studied HBOT in this setting. 47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64 An advantage of HBOT in these patients is the absence of the adverse effects on bladder structure or function that may be seen with other therapies, such as formalin or silver nitrate instillations, while avoiding the need for surgery. HBOT is also very well tolerated, with few adverse effects-the most common being pressure-related in the form of ear and sinus barotrauma.…”

Section: Hyperbaric Oxygen Therapymentioning

confidence: 99%

Management of radiation cystitis

2010

View full text Add to dashboard Cite

Acute radiation cystitis occurs during or soon after radiation treatment. It is usually self-limiting, and is generally managed conservatively. Late radiation cystitis, on the other hand, can develop from 6 months to 20 years after radiation therapy. The main presenting symptom is hematuria, which may vary from mild to severe, life-threatening hemorrhage. Initial management includes intravenous fluid replacement, blood transfusion if indicated and transurethral catheterization with bladder washout and irrigation. Oral or parenteral agents that can be used to control hematuria include conjugated estrogens, pentosan polysulfate or WF10. Cystoscopy with laser fulguration or electrocoagulation of bleeding points is sometimes effective. Injection of botulinum toxin A in the bladder wall may relieve irritative bladder symptoms. Intravesical instillation of aluminum, placental extract, prostaglandins or formalin can also be effective. More-aggressive treatment options include selective embolization or ligation of the internal iliac arteries. Surgical options include urinary diversion by percutaneous nephrostomy or intestinal conduit, with or without cystectomy. Hyperbaric oxygen therapy (HBOT) involves the administration of 100% oxygen at higher than atmospheric pressure. The reported success rate of HBOT for radiation cystitis varies from 60% to 92%. An important multicenter, doubleblind, randomized, sham-controlled trial to evaluate the effectiveness of HBOT for refractory radiation cystitis is currently being conducted.

show abstract

Hyperbaric oxygen therapy for radiation‐induced hemorrhagic cystitis

Cited by 46 publications

References 9 publications

Is there a role for hyberbaric oxygen as primary treatment for grade IV radiation-induced haemorrhagic cystitis? a prospective pilot-feasibility study and review of literature

Is there a role for hyberbaric oxygen as primary treatment for grade IV radiation-induced haemorrhagic cystitis? a prospective pilot-feasibility study and review of literature

Oxygenation inhibits ovarian tumor growth by down-regulating STAT3 and cyclin-D1 expressions

Management of radiation cystitis

Contact Info

Product

Resources

About